NantHealth (NASDAQ:NH) is set to announce its earnings results after the market closes on Wednesday, March 14th. Analysts expect the company to announce earnings of ($0.14) per share for the quarter.
NantHealth (NASDAQ NH) traded down $0.01 during mid-day trading on Friday, hitting $3.67. 87,126 shares of the company’s stock were exchanged, compared to its average volume of 106,230. NantHealth has a 12-month low of $2.60 and a 12-month high of $6.43. The stock has a market capitalization of $396.49 and a PE ratio of -2.51. The company has a debt-to-equity ratio of 0.93, a current ratio of 2.38 and a quick ratio of 2.36.
In related news, COO Ronald Allen Louks sold 7,095 shares of the business’s stock in a transaction dated Tuesday, March 6th. The shares were sold at an average price of $3.56, for a total transaction of $25,258.20. Following the sale, the chief operating officer now owns 89,690 shares of the company’s stock, valued at $319,296.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold a total of 19,745 shares of company stock worth $66,549 in the last ninety days. Insiders own 58.00% of the company’s stock.
A number of equities analysts have issued reports on the stock. BidaskClub upgraded shares of NantHealth from a “strong sell” rating to a “sell” rating in a research report on Tuesday, January 9th. Zacks Investment Research upgraded shares of NantHealth from a “hold” rating to a “buy” rating and set a $4.25 price objective on the stock in a research report on Thursday, January 11th. Finally, Canaccord Genuity cut their target price on shares of NantHealth from $6.00 to $5.00 and set a “buy” rating on the stock in a research note on Friday, November 17th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $8.05.
TRADEMARK VIOLATION WARNING: This article was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://stocknewstimes.com/2018/03/10/nanthealth-nh-set-to-announce-earnings-on-wednesday.html.
NantHealth Company Profile
NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.